The first two murine models of IDH1(R132H) mutation provide mechanistic insights into transformation. In hematopoietic cells, inhibition of TET2 and histone demethylases leads to epigenetic alterations and accumulation of hematopoietic precursors. In the central nervous system, inhibition of collagen and prolyl hydroxylases lead to altered microenvironment and defective angiogenesis
Mutations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene were recently discovered in vast ...
Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydr...
Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia w...
The first two murine models of IDH1(R132H) mutation provide mechanistic insights into transformation...
Mutations in the isocitrate dehydrogenase-1 gene (IDH1) are common drivers of acute myeloid leukemia...
Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently found in hum...
The hematopoietic system is a highly versatile regenerative tissue, in which hematopoietic stem cell...
TF-1 cells can induce DNA and histone hypermethylation that mirrors human IDH2 mutant acute myeloid ...
Isocitrate dehydrogenase 1 (IDH1) mutations occur in most lower grade glioma and not only drive glio...
Isocitrate dehydrogenase 1 and 2 (IDH1/2) are enzymes recurrently mutated in various types of cancer...
SummaryCancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme a...
Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significan...
Mutations in the metabolic enzymes isocitrate dehydrogenase-1 (IDH1) and IDH2 that produce the oncom...
Mutations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene were recently discovered in vast ...
Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydr...
Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia w...
The first two murine models of IDH1(R132H) mutation provide mechanistic insights into transformation...
Mutations in the isocitrate dehydrogenase-1 gene (IDH1) are common drivers of acute myeloid leukemia...
Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently found in hum...
The hematopoietic system is a highly versatile regenerative tissue, in which hematopoietic stem cell...
TF-1 cells can induce DNA and histone hypermethylation that mirrors human IDH2 mutant acute myeloid ...
Isocitrate dehydrogenase 1 (IDH1) mutations occur in most lower grade glioma and not only drive glio...
Isocitrate dehydrogenase 1 and 2 (IDH1/2) are enzymes recurrently mutated in various types of cancer...
SummaryCancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme a...
Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significan...
Mutations in the metabolic enzymes isocitrate dehydrogenase-1 (IDH1) and IDH2 that produce the oncom...
Mutations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene were recently discovered in vast ...
Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydr...
Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia w...